Drug Type Enzyme |
Synonyms Asparaginase (Recombinant), Asparaginase (USAN), Asparaginase Erwinia chrysanthemi (USAN) + [11] |
Target |
Action inhibitors |
Mechanism ASN inhibitors(Asparagine inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (14 Jan 2016), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02997 | Asparaginase |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Lymphoblastic Leukemia | Iceland | 14 Jan 2016 | |
Acute Lymphoblastic Leukemia | European Union | 14 Jan 2016 | |
Acute Lymphoblastic Leukemia | Liechtenstein | 14 Jan 2016 | |
Acute Lymphoblastic Leukemia | Norway | 14 Jan 2016 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Burkitt Lymphoma | Phase 2 | Brazil | 26 Apr 2019 | |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Phase 2 | Brazil | 26 Apr 2019 | |
Acute Lymphoblastic Leukemia | Phase 2 | Netherlands | 01 Oct 2008 |
Not Applicable | 502 | (Hematology/Oncology Specialists) | iyhmmtwrjq(dnohiuacht) = ztyqyllpke ooljhiycgg (vdzexggfft ) | Negative | 14 May 2024 | ||
Phase 3 | 1,645 | Quality-of-Life Assessment+Etoposide+Asparaginase+Cytarabine+Daunorubicin Hydrochloride+Mitoxantrone Hydrochloride (Arm A) | hwstpdkzbq(pfrquohuys) = rpezhnawsv guuhbpbleq (mceajxfisi, aplterqsco - odvwhumxdg) View more | - | 07 Jul 2020 | ||
Quality-of-Life Assessment+Etoposide+Asparaginase+bortezomib+Cytarabine+Daunorubicin Hydrochloride+Mitoxantrone Hydrochloride (Arm B) | hwstpdkzbq(pfrquohuys) = mwabnfomkd guuhbpbleq (mceajxfisi, mznwsuqogl - qcolnwllgm) View more | ||||||
Not Applicable | - | tlnkbjrvdm(odjxlqfysn) = twvqmrglde uwlazhbofm (vxixeyttua ) View more | Positive | 14 May 2020 | |||
Not Applicable | 135 | (rmavkmjqzg) = qgwrzdbxci ljrjmvsgin (wphcfarlhs ) | Negative | 14 May 2020 | |||
Phase 3 | 1,070 | (Arm A: Standard Arm - No GMTZ, AML Pts w/Out Down Syndrome) | jeduprlbkt(arvrpuvfhb) = xvlzqorcqt hohdvngiip (ncbhedvgqr, biakbukdop - koyojptonz) View more | - | 13 Jan 2015 | ||
etoposide+gemtuzumab ozogamicin+asparaginase+cytarabine+mitoxantrone hydrochloride+daunorubicin hydrochloride (Arm B: Experimental - With GMTZ, AML Pts w/Out Down Syndrome) | jeduprlbkt(arvrpuvfhb) = unjvzmfnko hohdvngiip (ncbhedvgqr, lyebqojgwh - zqvgnfjnjq) View more |